top of page

Wanjiru Waweru, Jadetimes Contributor

W. Waweru is a Jadetimes News Reporter Covering America and Business News

Labor Market Stumbled in September as Jobs Increased by 29,000, Unemployment Rate Rose to 4.2%
Image Source: Wanjiru Waweru

The U.S. economy saw fewer job opportunities in September, leading to a shocking position for the labor market and the broader economy.


Nowfarm Payrolls had made an adjustment to raise up to 29,000 for the month while the unemployment rate rose to 4.2%, the Bureau of Labor Statistics reported Friday, October 2. Dow Jones surveyed the economy and found job growth of 84,000 and an unemployment rate of 4.1%.

Additionally, in September, the August jobs went up to 133,000, while July had gone down to 10,000. Subsequently, the revisions appeared to be 60,000 fewer jobs.


Market reaction changed to the report, with traders interpreting the number of soft jobs as good news; furthermore, the Federal Reserve set an arrangement for the October meeting.


Stock futures increased directly with the following: Treasury Yields collapsed after increasing to levels not seen since the early part of the 21st Century. Market implied odds that the Fed would be held as its October 27-28 meeting rose to 82.8%, as stated by CME Group’s Fed Watch tool.


Thomas Simons, a chief U.S. Economist at Jefferies, took some notes.


“For the Fed, this number should be the nail in the coffin for an October hike,” said Simons. “The payroll data surged in August, and we had expected the momentum to continue this month, given the historically low prints on jobless claims in recent weeks. However, it now appears that the August number was nothing more than a rebound from very weak hiring in June and July.” 


Fed officials are watching the unemployment rate more than the headlines of payroll numbers.


Household employment increased by 406,000 for the month, while the labor force expanded, and the participation rate, which determines those working or currently seeking a job as a share of the total labor force, rose 0.2% to 61.8%, its highest since May.


A substitute measure of unemployment, such as discouraged workers and placing a part-time job on hold, which is economically reasonable, narrowed to 7.6%, its lowest level since January 2025.


The report arrives as Federal Reserve officials evaluate the state of the economy and how it should impact their next interest rate move.


Following statements in recent days from central bank policymakers, markets have faced recalibrated expectations and are now predicting that the rate-setting Federal Open Market Committee (FOMC) will maintain rates until December for the following hike. The FOMC increased benchmark rates by a quarter percentage point in September.


Policymakers predominantly view inflation as a larger threat to the economy than the labor market, which has shown resilience in recent months. The data have shown the population of a low-hire, low-fire economy, with weekly jobless claims low and one indicator seeing layoffs at their lowest rate in four years.


Although inflation has postponed the Fed's 2% target. The most recent indicator of the central bank’s preferred gauge showed a 3% annual rate.


Wages, however, continue to show evidence of disinflation.


Average hourly earnings rose just 0.1% in September, placing the 12-month gain at 3%, the lowest since May 2021. Wall Street had been searching for readings of 0.3% and 3.1%, respectively. The average workweek has been adjusted to 34.6 hours.


Labor Market Stumbled in September as Jobs Increased by 29,000, Unemployment Rate Rose to 4.2%
Image Source: CNBC

Heather Long, chief economist at Navy Federal Credit Union, is very disappointed about this situation.


“Americans are frustrated by the lack of opportunities right now,” said Long. “Wage growth fell to a new 5-year low and is being wiped out entirely by inflation. That stings heading into the holidays.” 


Furthermore, Long described the labor market as “steady” and stated she does not think the Fed would be debating hiking in December.


Labor Market Stumbled in September as Jobs Increased by 29,000, Unemployment Rate Rose to 4.2%
Image Source: Wanjiru Waweru

Most of the monthly job additions came from Healthcare, which added 17,000 workers. Construction rose 11,000, and manufacturing added 9,000.


Government employment increased by 17,000, while temporary support services saw a decrease of 11,000, and information services lost 10,000 amid concerns over the effect artificial intelligence may have on the availability of jobs. Financial activities saw a decrease of 7,000 jobs.


The job market weakened in strength and growth.


On a macro level, economic growth has been improving.


So far, the Commerce Department altered its count of both first- and second-quarter domestic product growth to 2.5% and 2.2%. The Atlanta Fed is monitoring third-quarter GDP at 3.7%.


About Wanjiru Waweru


Wanjiru Waweru is a Jadetimes Contributor. You can email Wanjiru at sellmypaperwork@gmail.com.

She is the Owner of “Sell My Paperwork." Visit the website and follow it on social media.


Sell My Paperwork


YouTube:  @sellmypaperwork

Khoshnaw Rahmani, Jadetimes Staff

K. Rahmani is a Jadetimes news reporter covering culture.

REUTERS/Manami Yamada
REUTERS/Manami Yamada

Nvidia's ambitious effort to use artificial-intelligence chips as the foundation for a massive financing market is facing increasing scrutiny from banks and investors, who remain uncertain about how much value the hardware will retain over the long term.


The debate centers on Nvidia's proposed $500 billion financing initiative, which is designed to help AI companies secure funding for computing infrastructure by using Nvidia's chips as collateral.

While Nvidia views its advanced processors as durable, income-generating assets, some lenders and asset managers are taking a more cautious approach.


Banks Seek Stronger Protection


People familiar with discussions around potential financing deals told Reuters that some lenders want stronger guarantees than Nvidia initially proposed.


The concern is largely about the future earning power and resale value of AI processors.


Although Nvidia's chips currently provide critical computing capacity for AI systems, financial institutions must determine how long individual generations of hardware will continue producing reliable cash flows as newer technology enters the market.


Some investors therefore remain hesitant to treat the chips as traditional long-term collateral.

Tony Trzcinka, a senior portfolio manager at Impax Asset Management, said Wall Street's assessment of the longevity of Nvidia's specialized chips is more conservative than the company's own expectations.


Nvidia Defends the Value of Its Hardware


Nvidia maintains that its AI computing infrastructure can support long-term financing.

The company describes its AI computing assets as productive, durable and interchangeable, arguing that they can generate economic value over extended periods.


An Nvidia spokesperson said financing partners independently evaluate individual opportunities by considering factors such as customer commitments, anticipated cash flows and the residual value of the equipment.


The company also acknowledged that financing structures are likely to evolve as the market develops.


$500 Billion Financing Ambition


Nvidia announced the financing initiative in August with financial firms including Blackstone, Apollo and KKR.

The strategy is intended to create a new financing ecosystem around AI computing infrastructure, allowing AI developers to gain access to Nvidia's expensive processors through financing arrangements.

The concept has been compared with financing structures used in other capital-intensive industries, including aircraft leasing.


Nvidia has said some transactions could include residual-value guarantees of no more than 25%, limiting the company's exposure while allowing financing partners to participate.


However, the relatively limited guarantees have raised questions among some investors about who would ultimately absorb losses if the value of the equipment declines faster than expected.


AI Investment Raises Financing Questions


The debate comes as companies around the world are committing hundreds of billions of dollars to AI-related infrastructure, including data centers, processors and electricity capacity.


The enormous scale of investment has increased attention on how these projects are being financed and whether the underlying assets will generate sufficient returns over time.


Some analysts have also raised concerns about the growing use of private credit, vendor financing and interconnected transactions in the AI sector.


Morningstar analysts recently noted similarities between some of these financing structures and arrangements that became prominent during the technology boom more than two decades ago, although the current market involves different technologies and economic conditions.


More Conservative Deals Emerging


People familiar with financing discussions said transactions currently in development may include stronger guarantees and other protections for investors.


That could provide lenders with greater confidence while allowing Nvidia and its partners to continue expanding the financing market around AI computing.


The central question for investors remains how long today's high-end AI processors can continue generating strong economic returns once newer generations of chips become available.


As the AI infrastructure boom continues, the answer could influence not only Nvidia's financing strategy but also the cost and availability of capital for companies building the next generation of AI data centers.

Hadisur Rahman, JadeTimes Staff

H. Rahman is a Jadetimes news reporter covering the USA

Trump
REUTERS/Dado Ruvic/Illustration

A new Trump administration policy aimed at lowering prescription drug costs for Medicare patients could ultimately apply to only four pharmaceutical companies, after the government created exemptions for manufacturers that have reached separate pricing agreements with the White House.


The policy is part of a Medicare drug-pricing initiative known as GLOBE, which seeks to change how certain hospital-administered medicines covered by Medicare are priced.


Under the final rule published Wednesday, the Centers for Medicare & Medicaid Services plans to exempt drugmakers that have entered separate “most favored nation” pricing agreements with the Trump administration from participating in the GLOBE model.


Only Four Companies Could Remain


The final rule indicates that the number of drug manufacturers subject to the model could fall to four after the exemptions are applied.


A footnote in the regulation identifies the potential number but does not name the companies that would remain covered by the program.


The exemptions could significantly narrow the scope of the pricing initiative compared with the administration's original proposal.


Projected Medicare Savings Slashed


The final version of the policy also contains a major reduction in the government's projected financial savings.


The Department of Health and Human Services now estimates that the program will reduce Medicare Part B spending by approximately $440 million over the model period.


That figure is dramatically lower than the approximately $11.9 billion in savings projected when the rule was initially proposed.


HHS did not immediately explain why its estimate of potential savings had fallen so sharply.


Drugmakers Have Signed Separate Agreements


The Trump administration has reached separate pricing agreements with more than two dozen pharmaceutical companies since launching its broader drug-pricing initiative last year.


The companies include several of the world's largest drugmakers, such as Pfizer, Eli Lilly and Novo Nordisk.

The separate agreements are intended to establish lower drug prices under arrangements negotiated with the administration.


According to estimates from the White House Council of Economic Advisers, the broader drug-pricing effort could generate approximately $27.6 billion in savings for state governments and $36.6 billion for the federal government over the next decade.


Questions Remain Over the Model's Impact


The reduced number of participating manufacturers and the sharp decline in projected Medicare savings could limit the direct financial impact of the GLOBE model.


The final rule nevertheless represents another component of the administration's wider effort to reduce prescription drug costs and change how pharmaceutical prices are determined for government programs.


The actual impact of the model will depend on which manufacturers ultimately remain subject to its pricing requirements and how the program is implemented.

bottom of page